Samantha Prout is CAO at AMICUS THERAPEUTICS, INC. (FOLD). They have made 4 open-market trades across 1 company since 2020, most recently 2026-01-03.
CIK 0001743122
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FOLD | 125,951 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-01-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FOLD | SELL · 10b5-1 | 2024-01-08 | 2024-01-09 | $14.00 | $449K | -8.9% | -2.3% | -15.0% |
| FOLD | SELL · 10b5-1 | 2023-12-26 | 2023-12-28 | $14.00 | $107K | -6.3% | -10.4% | -18.1% |
| FOLD | SELL · 10b5-1 | 2023-08-09 | 2023-08-11 | $14.01 | $1.0M | -5.0% | -0.2% | -25.1% |
| FOLD | SELL | 2021-09-03 | 2021-09-08 | $12.01 | $118K | -4.1% | +0.5% | -2.1% |
| FOLD | SELL | 2021-08-23 | 2021-08-25 | $11.00 | $55K | +3.2% | -1.5% | +2.7% |
| FOLD | SELL | 2020-11-04 | 2020-11-06 | $20.00 | $119K | +8.9% | +12.9% | -1.4% |
| FOLD | SELL · 10b5-1 | 2020-08-05 | 2020-08-07 | $15.05 | $3K | -1.5% | -10.2% | +42.0% |
| FOLD | SELL · 10b5-1 | 2020-07-02 | 2020-07-06 | $15.80 | $3K | -0.9% | -2.6% | -7.4% |
| FOLD | SELL | 2020-06-19 | 2020-06-23 | $15.00 | $50K | +1.2% | -4.4% | -12.5% |
| FOLD | SELL · 10b5-1 | 2020-06-16 | 2020-06-17 | $12.95 | $38K | +20.3% | +17.7% | +7.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.